Cyclophosphamide enhances anti-tumor effects of a fibroblast activation protein α-based DNA vaccine in tumor-bearing mice with murine breast carcinoma

Anti-tumor effects of DNA vaccine targeting human fibroblast activation protein α by producing specific immune responses and altering tumor microenvironment in the 4T1 murine breast cancer model

(2016) Qiu Xia et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

MUC1 and survivin combination tumor gene vaccine generates specific immune responses and anti-tumor effects in a murine melanoma model

(2016) Haihong Zhang et al.   VACCINE

Imaging the Tumor Microenvironment

(2015) Valerie S. LeBleu   CANCER JOURNAL

Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells

(2015) A. Lo et al.   CANCER RESEARCH

Enhanced Dendritic Cell–based Immunotherapy Using Low-dose Cyclophosphamide and CD25-targeted Antibody for Transplanted Lewis Lung Carcinoma Cells

(2015) Cheol-Hun Son et al.   JOURNAL OF IMMUNOTHERAPY

T cell exclusion, immune privilege, and the tumor microenvironment

(2015) J. A. Joyce et al.   SCIENCE

A whole-cell tumor vaccine modified to express fibroblast activation protein induces antitumor immunity against both tumor cells and cancer-associated fibroblasts

(2015) Meihua Chen et al.   Scientific Reports

Effective Chemoimmunotherapy with Anti-TGFβ Antibody and Cyclophosphamide in a Mouse Model of Breast Cancer

(2014) Xin Chen et al.   PLoS One

Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors

(2013) J. Duraiswamy et al.   CANCER RESEARCH

Enhancement of survivin-specific anti-tumor immunity by adenovirus prime protein-boost immunity strategy with DDA/MPL adjuvant in a murine melanoma model

(2013) Yu-Qian Wang et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Cancer Immunotherapy

(2013) J. Couzin-Frankel   SCIENCE

Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy

(2013) Christel Devaud et al.   OncoImmunology

Fibroblast activation protein

(2012) Rui Liu et al.   CANCER BIOLOGY & THERAPY

DNA and adenovirus tumor vaccine expressing truncated survivin generates specific immune responses and anti-tumor effects in a murine melanoma model

(2012) Haihong Zhang et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

(2012) Steffen Walter et al.   NATURE MEDICINE

Combination of lentivector immunization and low-dose chemotherapy or PD-1/PD-L1 blocking primes self-reactive T cells and induces anti-tumor immunity

(2011) Sophie R. Sierro et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model

(2010) Yuan Wen et al.   CANCER SCIENCE

Cancer Associated Fibroblasts Promote Tumor Growth and Metastasis by Modulating the Tumor Immune Microenvironment in a 4T1 Murine Breast Cancer Model

(2009) Debbie Liao et al.   PLoS One

High dose cyclophosphamide performs better than monthly dose cyclophosphamide in quality of life measures

(2008) KB Dussán et al.   LUPUS